Salcaprozate Sodium
ExcipientCAS 203787-91-1UNII 1YTW0422YU
30 organisations hold 31 active FDA Type IV Drug Master Files for Salcaprozate Sodium.
Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology
Active Type IV DMFs (31)
| Holder | DMF | Filed as | Submitted |
|---|---|---|---|
| CHANGZHOU SUNLIGHT PHARMACEUTICAL CO LTD | 44368 | SALCAPROZATE SODIUM | Sept 2026 |
| SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD China | 43393 | SALCAPROZATE SODIUM | Jun 2026 |
| ZHEJIANG AUSUN PHARMACEUTICAL CO LTD China | 44148 | SALCAPROZATE SODIUM | Jun 2026 |
| PHARMSYN CO LTD | 43222 | SALCAPROZATE SODIUM (SNAC) | Apr 2026 |
| SOLARA ACTIVE PHARMA SCIENCES LTD India | 43784 | SALCAPROZATE SODIUM | Apr 2026 |
| MICRO LABS LTD India | 42780 | SALCAPROZATE SODIUM | Apr 2026 |
| HEFEI TIANRUI PHARMACEUTICAL CHEMICAL CO LTD China | 43961 | SALCAPROZATE SODIUM - PROCESS II | Mar 2026 |
| MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTD | 43745 | SALCAPROZATE SODIUM | Mar 2026 |
| Alembic Pharmaceuticals Limited India | 43625 | SALCAPROZATE SODIUM | Feb 2026 |
| HONOUR LAB LTD India | 40329 | SALCAPROZATE SODIUM | Feb 2026 |
| CHANGZHOU PHARMACEUTICAL FACTORY China | 43294 | SALCAPROZATE SODIUM | Dec 2025 |
| OLON SPA Italy | 43008 | SALCAPROZATE SODIUM | Dec 2025 |
| ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO LTD China | 42303 | SALCAPROZATE SODIUM | Aug 2025 |
| NANJING ABYDOS PHARMA TECHNOLOGY CO LTD | 42103 | SALCAPROZATE SODIUM | Jul 2025 |
| Chongqing Sintaho Pharmaceutical Co., Ltd. China | 41721 | SALCAPROZATE SODIUM | Apr 2025 |
| ALLSINO PHARMACEUTICAL CO LTD China | 41615 | SALCAPROZATE SODIUM | Mar 2025 |
| EAGLE CHEMICAL WORKS | 41533 | SALCAPROZATE SODIUM | Mar 2025 |
| AMI LIFESCIENCES PRIVATE LTD India | 40707 | SALCAPROZATE SODIUM | Nov 2024 |
| QIDONG DONGYUE PHARMACEUTICAL CO LTD China | 40767 | SALCAPROZATE SODIUM | Nov 2024 |
| Cipla Limited India | 39618 | SALCAPROZATE SODIUM | Oct 2024 |
| BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED India | 40217 | SALCAPROZATE SODIUM | Jul 2024 |
| CHONGQING BIOLAND PHARMACEUTICAL LTD China | 40177 | SALCAPROZATE SODIUM | Jul 2024 |
| ANHUI BEIRUI PHARMACEUTICAL TECHNOLOGY CO LTD | 40147 | SALCAPROZATE SODIUM | Jun 2024 |
| XIAMEN SINOPEG BIOTECH CO LTD China | 40072 | SALCAPROZATE SODIUM (SNAC) | Jun 2024 |
| ANHUI POLY PHARM CO LTD China | 39651 | SALCAPROZATE SODIUM | Mar 2024 |
| SICHUAN PUKANG PHARMACEUTICAL CO LTD | 39196 | SALCAPROZATE SODIUM | Nov 2023 |
| Dr. Reddy's Laboratories Ltd. India | 38202 | SALCAPROZATE SODIUM | Mar 2023 |
| MATRIX PHARMACORP PRIVATE LTD India | 37682 | SALCAPROZATE SODIUM | Dec 2022 |
| HEFEI TIANRUI PHARMACEUTICAL CHEMICAL CO LTD China | 37135 | SALCAPROZATE SODIUM | May 2022 |
| NAVINTA LLC United States | 36388 | SALCAPROZATE SODIUM | Oct 2021 |
| MAITHRI LABORATORIES PRIVATE LTD India | 35672 | SALCAPROZATE SODIUM | Mar 2021 |
“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.
What these records establish
- A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
- Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
- The holder is the organisation that filed. It is usually, but not always, the manufacturer.
- Many excipients are supplied without any DMF, so this list is not every supplier of Salcaprozate Sodium.
For suppliers
Do you supply Salcaprozate Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.